| 000 | 01327 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513122233.0 | ||
| 264 | 0 | _c19970804 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeden, H | |
| 245 | 0 | 0 |
_aMaintenance chemotherapy with oral treosulfan following first-line treatment in patients with advanced ovarian cancer: feasibility and toxicity. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a2221-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aBusulfan _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aWittkop, Y | |
| 700 | 1 | _aKuhn, W | |
| 773 | 0 |
_tAnticancer research _gvol. 17 _gno. 3C _gp. 2221-3 |
|
| 999 |
_c9197051 _d9197051 |
||